PACS Group Q3 2026 Earning Call - PACS GROUP INC

Explicit Guidance:

• FY2026 Revenue: Increased guidance to $5.95 billion – $6.05 billion (range midpoint represents ~13% growth vs. 2025).
• FY2026 Adjusted EBITDA: Increased guidance to $685 million – $695 million (range midpoint represents ~37% growth vs. 2025).
• Guidance includes $5 million EBITDA contribution from retroactive Ohio quality incentive payments received in October 2026.
• Revenue and EBITDA ranges incorporate contributions from newly acquired Florida (32 facilities) and Texas (11 facilities) operations for the remainder of the year.
• Outlook assumes planned near-term integration investments for Florida and Texas facilities, which are expected to suppress near-term operating margins before realizing long-term value.
• 2027 Outlook: No formal guidance provided; management expects normalization of earnings by removing one-time California WQIP payments (with one final expected in Q1 2027) and layering in same-store growth and embedded earnings from ramping transactions.

Business-Segment Outlook:

• Same-Store Growth: Expects continued organic revenue growth at ~6.4% annually, driven by occupancy and skilled mix improvements in the established 284-facility base.
• Acquisition Integration: Anticipates significant operating improvements in new cohorts (Aduro, Florida, Texas) as they transition from "new" to "ramping" (18 months) to "mature" status.
• Operational Targets: Mature facilities currently operate at 93.1% occupancy and 31.3% skilled mix; long-term target is 100% occupancy and 100% skilled mix.
• Ramping Cycle: Expect continued strong performance from the 90 ramping facilities and 35 new facilities as they absorb PACS clinical systems and leadership support.
• New Cohorts: Newly acquired facilities (including Florida and Aduro) entered at lower baselines (76-87% occupancy, 21-26% skilled mix) with a projected 16.9 percentage point occupancy gap and 10.2 percentage point skilled mix gap relative to mature facilities.

Market and Competitive Outlook:

• Florida Expansion: Entering Florida with 32 facilities seen as a "meaningful presence"; management views state average occupancy and skilled mix as relatively high, presenting value-add opportunities.
• M&A Pipeline: Observing a "huge influx" of deals, particularly in new states where presence is established (e.g., Texas, Florida), though pipeline remains opportunistic and disciplined.
• Deal Profile: Focus remains on moderately performing, underperforming, or distressed facilities; no specific target for annual deal count or deal size, but capability to execute large portfolio acquisitions is confirmed.
• Tuck-in Opportunities: Expecting increased tuck-in transaction flow in communities where PACS has established a strong footprint and reputation.
• Labor Market: Anticipates continued favorable trends in staffing availability, specifically in Florida and Texas, with agency usage expected to be ahead of schedule for elimination.

Macro / Industry Outlook:

• Regulatory Environment: Maintains a measured view on potential shifts due to election outcomes; acknowledges potential for increased regulatory scrutiny (e.g., minimum staffing) under Democratic control but expects offsetting relief in reimbursement rates/funding from entitlement programs.
• Reimbursement Trends: Observing a shift toward value-based models where Medicaid and Medicare rates correlate directly with quality outcomes and acuity management; expects this trend to continue.
• Quality Ratings: Notes CMS star rating methodology adjustments and cut points are moving; anticipates continued improvement in ratings as operational focus remains on clinical excellence.
• Demographics: Cites "serious tailwinds" from demographic trends supporting long-term demand for skilled nursing services.
• State Dynamics: Florida regulatory and reimbursement landscape noted as improved over the last several years compared to historical challenges.

Strategic Initiatives:

• Florida Acquisition: Completed acquisition of 32 skilled nursing operations (4,049 beds) on October 1, 2026; priority is establishing regional leadership and clinical support.
• Texas Expansion: Completed acquisition of 10 skilled nursing operations and 1 assisted living operation on November 1, 2026; aims to deepen existing market presence.
• Real Estate Strategy: Opportunistically purchasing underlying real estate (e.g., 6 properties in Q3); balancing capital allocation between owned real estate vs. operational investment based on "highest and best use."
• Leadership Development: Currently training 54 Administrator in Training (AIT) candidates to support expansion and facility leadership pipelines.
• Internal Controls: Expecting full remediation of material weaknesses in internal controls by year-end 2026 to conclude effectiveness testing.
• Share Repurchases: Retaining authorization for $250 million in share buybacks, available for opportunistic execution.

Risks and Headwinds to Outlook:

• Integration Costs: Near-term EBITDA impact expected from integration investments required for Florida and Texas facilities before operating improvements materialize.
• Acquisition Mix: Consolidated metrics (occupancy, skilled mix) currently pressured by newly acquired facilities entering at lower baselines compared to the mature portfolio.
• Regulatory Uncertainty: Ongoing government investigations remain a variable regarding timing and outcome, though management remains confident in constructive engagement.
• Policy Changes: Potential for punitive regulatory policies (e.g., minimum staffing mandates) if political landscape shifts, though company believes it has infrastructure to adapt.
• Payment Timeliness: One-time quality incentive payments (e.g., Ohio $5M, future CA WQIP) are excluded from long-term normalized outlooks; reliance on these for 2026 upside is specific to the current period.

Management Tone on the Future:

• Confidence: High confidence in organic growth, operating model scalability, and ability to turn around acquired assets; uses phrases like "hitting a new gear" and "significant opportunities ahead."
• Discipline: Repeated emphasis on "disciplined growth" and refusing to pursue deals for growth's sake; underwriting criteria remain strict despite a crowded M&A pipeline.
• Operational Momentum: Expresses strong belief that "existing operations are humming along," allowing the company to fund integration investments while still increasing full-year guidance.
• Strategic Clarity: Views the expansion into new states (FL, TX) and the integration of distressed assets as core to value creation rather than pure expansion risk.

Miscellaneous:

• Cash Flow: Generated $583.1 million in operating cash flow for the first nine months of 2026; DSO decreased by 2-3 days due to improved collections.
• Liquidity: Ended September 2026 with $707.4 million available liquidity (including $115.3 million cash) and net leverage of 0.2x.
• Quality Metrics: 78.9% of skilled nursing facilities (250 facilities) hold 4- or 5-star CMS ratings; mature facilities average 4.5 stars.
• Specific Facility Turnaround: Successfully graduated one Tennessee facility from "Special Focus Facility" status in September 2026 after 25+ in-service training sessions, raising occupancy from ~70% to ~85%.
• Non-GAAP Measures: Adjusted EBITDA includes a $4.4 million benefit from California WQIP; GAAP rent expense exceeded cash payments by $10.1 million in Q3.